Cargando…

Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide

BACKGROUND: MUC7 12-mer (RKSYKCLHKRCR), a cationic antimicrobial peptide derived from the human low-molecular-weight salivary mucin MUC7, possesses potent antimicrobial activity in vitro. In order to evaluate the potential therapeutic application of the MUC7 12-mer, we examined the effects of mono-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Guo-Xian, Campagna, Alexander N, Bobek, Libuse A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211505/
https://www.ncbi.nlm.nih.gov/pubmed/17996119
http://dx.doi.org/10.1186/1476-0711-6-14
_version_ 1782148531266519040
author Wei, Guo-Xian
Campagna, Alexander N
Bobek, Libuse A
author_facet Wei, Guo-Xian
Campagna, Alexander N
Bobek, Libuse A
author_sort Wei, Guo-Xian
collection PubMed
description BACKGROUND: MUC7 12-mer (RKSYKCLHKRCR), a cationic antimicrobial peptide derived from the human low-molecular-weight salivary mucin MUC7, possesses potent antimicrobial activity in vitro. In order to evaluate the potential therapeutic application of the MUC7 12-mer, we examined the effects of mono- and divalent cations, EDTA, pH, and temperature on its antimicrobial activity. METHODS: Minimal Inhibitory Concentrations (MICs) were determined using a liquid growth inhibition assay in 96-well microtiter plates. MUC7 12-mer was added at concentrations of 1.56–50 μM. MICs were determined at three endpoints: MIC-0, MIC-1, and MIC-2 (the lowest drug concentration showing 10%, 25% and 50% of growth, respectively). To examine the effect of salts or EDTA, a checkerboard microdilution technique was used. Fractional inhibitory concentration index (FICi) was calculated on the basis of MIC-0. The viability of microbial cells treated with MUC7 12-mer in the presence of sodium or potassium was also determined by killing assay or flow cytometry. RESULTS: The MICs of MUC7 12-mer against organisms tested ranged from 6.25–50 μM. For C. albicans, antagonism (FICi 4.5) was observed for the combination of MUC7 12-mer and calcium; however, there was synergism (FICi 0.22) between MUC7 12-mer and EDTA, and the synergism was retained in the presence of calcium at its physiological concentration (1–2 mM). No antagonism but additivity or indifference (FICi 0.55–2.5) was observed for the combination of MUC7 12-mer and each K(+), Na(+), Mg(2+), or Zn(2+). MUC7 12-mer peptide (at 25 μM) also exerted killing activity in the presence of NaCl, (up to 25 mM for C. albicans and up to 150 mM for E. coli, a physiological concentration of sodium in the oral cavity and serum, respectively) and retained candidacidal activity in the presence of KCl (up to 40 mM). The peptide exhibited higher inhibitory activity against C. albicans at pH 7, 8, and 9 than at pH 5 and 6, and temperature up to 60°C did not affect the activity. CONCLUSION: MUC7 12-mer peptide is effective anticandidal agent at physiological concentrations of variety of ions in the oral cavity. These results suggest that, especially in combination with EDTA, it could potentially be applied as an alternative therapeutic agent for the treatment of human oral candidiasis.
format Text
id pubmed-2211505
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22115052008-01-22 Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide Wei, Guo-Xian Campagna, Alexander N Bobek, Libuse A Ann Clin Microbiol Antimicrob Research BACKGROUND: MUC7 12-mer (RKSYKCLHKRCR), a cationic antimicrobial peptide derived from the human low-molecular-weight salivary mucin MUC7, possesses potent antimicrobial activity in vitro. In order to evaluate the potential therapeutic application of the MUC7 12-mer, we examined the effects of mono- and divalent cations, EDTA, pH, and temperature on its antimicrobial activity. METHODS: Minimal Inhibitory Concentrations (MICs) were determined using a liquid growth inhibition assay in 96-well microtiter plates. MUC7 12-mer was added at concentrations of 1.56–50 μM. MICs were determined at three endpoints: MIC-0, MIC-1, and MIC-2 (the lowest drug concentration showing 10%, 25% and 50% of growth, respectively). To examine the effect of salts or EDTA, a checkerboard microdilution technique was used. Fractional inhibitory concentration index (FICi) was calculated on the basis of MIC-0. The viability of microbial cells treated with MUC7 12-mer in the presence of sodium or potassium was also determined by killing assay or flow cytometry. RESULTS: The MICs of MUC7 12-mer against organisms tested ranged from 6.25–50 μM. For C. albicans, antagonism (FICi 4.5) was observed for the combination of MUC7 12-mer and calcium; however, there was synergism (FICi 0.22) between MUC7 12-mer and EDTA, and the synergism was retained in the presence of calcium at its physiological concentration (1–2 mM). No antagonism but additivity or indifference (FICi 0.55–2.5) was observed for the combination of MUC7 12-mer and each K(+), Na(+), Mg(2+), or Zn(2+). MUC7 12-mer peptide (at 25 μM) also exerted killing activity in the presence of NaCl, (up to 25 mM for C. albicans and up to 150 mM for E. coli, a physiological concentration of sodium in the oral cavity and serum, respectively) and retained candidacidal activity in the presence of KCl (up to 40 mM). The peptide exhibited higher inhibitory activity against C. albicans at pH 7, 8, and 9 than at pH 5 and 6, and temperature up to 60°C did not affect the activity. CONCLUSION: MUC7 12-mer peptide is effective anticandidal agent at physiological concentrations of variety of ions in the oral cavity. These results suggest that, especially in combination with EDTA, it could potentially be applied as an alternative therapeutic agent for the treatment of human oral candidiasis. BioMed Central 2007-11-11 /pmc/articles/PMC2211505/ /pubmed/17996119 http://dx.doi.org/10.1186/1476-0711-6-14 Text en Copyright © 2007 Wei et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Wei, Guo-Xian
Campagna, Alexander N
Bobek, Libuse A
Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide
title Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide
title_full Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide
title_fullStr Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide
title_full_unstemmed Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide
title_short Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide
title_sort factors affecting antimicrobial activity of muc7 12-mer, a human salivary mucin-derived peptide
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211505/
https://www.ncbi.nlm.nih.gov/pubmed/17996119
http://dx.doi.org/10.1186/1476-0711-6-14
work_keys_str_mv AT weiguoxian factorsaffectingantimicrobialactivityofmuc712merahumansalivarymucinderivedpeptide
AT campagnaalexandern factorsaffectingantimicrobialactivityofmuc712merahumansalivarymucinderivedpeptide
AT bobeklibusea factorsaffectingantimicrobialactivityofmuc712merahumansalivarymucinderivedpeptide